Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Solid Biosciences (SLDB) Other Non Operating Income: 2017-2024

Historic Other Non Operating Income for Solid Biosciences (SLDB) over the last 6 years, with Dec 2024 value amounting to $199,000.

  • Solid Biosciences' Other Non Operating Income fell 26.30% to $199,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $652,000, marking a year-over-year decrease of 40.46%. This contributed to the annual value of $652,000 for FY2024, which is 40.46% down from last year.
  • Latest data reveals that Solid Biosciences reported Other Non Operating Income of $199,000 as of Q4 2024, which was down 5.69% from $211,000 recorded in Q3 2024.
  • Solid Biosciences' 5-year Other Non Operating Income high stood at $282,000 for Q1 2023, and its period low was -$355,000 during Q4 2022.
  • For the 3-year period, Solid Biosciences' Other Non Operating Income averaged around $124,455, with its median value being $211,000 (2024).
  • As far as peak fluctuations go, Solid Biosciences' Other Non Operating Income slumped by 99.53% in 2020, and later skyrocketed by 2,750.00% in 2023.
  • Over the past 4 years, Solid Biosciences' Other Non Operating Income (Quarterly) stood at $1,000 in 2020, then reached -$355,000 in 2022, then surged by 176.06% to $270,000 in 2023, then fell by 26.30% to $199,000 in 2024.
  • Its last three reported values are $199,000 in Q4 2024, $211,000 for Q3 2024, and $239,000 during Q2 2024.